Please use this identifier to cite or link to this item:
http://archive.cmb.ac.lk:8080/xmlui/handle/70130/7499
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jayakody, R.L. | - |
dc.date.accessioned | 2024-12-13T05:08:52Z | - |
dc.date.available | 2024-12-13T05:08:52Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Jayakody, R.L. (2020). The NMRA Act and Establishment of the NMRA. Colombo Medical Congress 2020, Faculty of Medicine, University of Colombo. | en_US |
dc.identifier.uri | http://archive.cmb.ac.lk:8080/xmlui/handle/70130/7499 | - |
dc.description.abstract | The National Medicines Regulatory Authority Act (NMRA Act) was enacted in March 2015 and the NMRA (the Authority) established in July 2015. The Cosmetics Devices and Drugs Act which was in operation since 1980 was repealed. The NMRA Act regulated all aspects pertaining to medicines, medical devices and borderline products. Regulation of simple cosmetics was removed from the purview of this Act. A 13 member Authority with ex officio and appointed members with expertise from different fields was instituted. The national testing laboratory was incorporated into the Authority. Areas regulated include import, local manufacture, pharmacies, prescribing, pricing and clinical trials. A National Standing Committee with oversight function and an Appeals Committee is included. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Faculty of Medicine, University of Colombo | en_US |
dc.subject | The National Medicines Regulatory Authority | en_US |
dc.title | The NMRA Act and Establishment of the NMRA | en_US |
dc.type | Other | en_US |
Appears in Collections: | Conference Papers |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.